These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 2112648)

  • 21. Thrombus in right atrium in two infants successfully treated with tissue plasminogen activator.
    Martínez-Tallo E; Campo F; Delgado M; Marfíl S; Agulla E
    Pediatr Emerg Care; 1997 Feb; 13(1):37-9. PubMed ID: 9061735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant urokinase is safe and effective in restoring patency to occluded central venous access devices: a multiple-center, international trial.
    Svoboda P; Barton RP; Barbarash OL; Butylin AA; Jacobs BR; Lata J; Haire WD; Jaff MR; Firszt CM; Mouginis TL; Schuerr DM; Schulz GA; Schwartz LB; El-Shahawy MA
    Crit Care Med; 2004 Oct; 32(10):1990-6. PubMed ID: 15483405
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stability and sterility of recombinant tissue plasminogen activator at -30 degrees C.
    Wiernikowski JT; Crowther M; Clase CM; Ingram A; Andrew M; Chan AK
    Lancet; 2000 Jun; 355(9222):2221-2. PubMed ID: 10881901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Techniques in dosing for thrombolysis of occluded central venous catheters.
    Haire WD
    Tech Vasc Interv Radiol; 2001 Jun; 4(2):127-30. PubMed ID: 11981800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and efficacy of alteplase for restoring function in occluded central venous catheters: results of the cardiovascular thrombolytic to open occluded lines trial.
    Deitcher SR; Fesen MR; Kiproff PM; Hill PA; Li X; McCluskey ER; Semba CP;
    J Clin Oncol; 2002 Jan; 20(1):317-24. PubMed ID: 11773185
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tissue plasminogen activator to prevent central venous access device infections: a systematic review of central venous access catheter thrombosis, infection and thromboprophylaxis.
    Ragni MV; Journeycake JM; Brambilla DJ
    Haemophilia; 2008 Jan; 14(1):30-8. PubMed ID: 18005145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Successful treatment of a catheter-related right atrial thrombosis with recombinant tissue plasminogen activator and heparin.
    Cesaro S; Paris M; Corrò R; Svaluto G; Zanon GF; Gamba P; Milanesi O; Messina C; Zanesco L
    Support Care Cancer; 2002 Apr; 10(3):253-5. PubMed ID: 11904791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serine-proteases as plasminogen activators in terms of fibrinolysis.
    Flemmig M; Melzig MF
    J Pharm Pharmacol; 2012 Aug; 64(8):1025-39. PubMed ID: 22775207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant tissue plasminogen activator (alteplase) for restoration of flow in occluded central venous access devices: a double-blind placebo-controlled trial--the Cardiovascular Thrombolytic to Open Occluded Lines (COOL) efficacy trial.
    Ponec D; Irwin D; Haire WD; Hill PA; Li X; McCluskey ER;
    J Vasc Interv Radiol; 2001 Aug; 12(8):951-5. PubMed ID: 11487675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of a large organized intraatrial catheter-tip thrombus in a child with acquired immunodeficiency syndrome using escalating tissue plasminogen activator infusions.
    Mathur M; Desai N; Sharma J; Rao SP; Goldman GM
    Pediatr Crit Care Med; 2005 Jan; 6(1):79-82. PubMed ID: 15636665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recombinant urokinase for restoration of patency in occluded central venous access devices. A double-blind, placebo-controlled trial.
    Haire WD; Deitcher SR; Mullane KM; Jaff MR; Firszt CM; Schulz GA; Schuerr DM; Schwartz LB; Mouginis TL; Barton RP
    Thromb Haemost; 2004 Sep; 92(3):575-82. PubMed ID: 15351854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of occluded central venous catheters with alteplase: results in 1,064 patients.
    Semba CP; Deitcher SR; Li X; Resnansky L; Tu T; McCluskey ER;
    J Vasc Interv Radiol; 2002 Dec; 13(12):1199-205. PubMed ID: 12471182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alteplase versus urokinase in restoring blood flow in hemodialysis-catheter thrombosis.
    Eyrich H; Walton T; Macon EJ; Howe A
    Am J Health Syst Pharm; 2002 Aug; 59(15):1437-40. PubMed ID: 12166043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urokinase administration in pediatric patients with occluded central venous catheters.
    Wachs T
    J Intraven Nurs; 1990; 13(2):100-2. PubMed ID: 2313458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safe and cost effective use of alteplase for the clearance of occluded central venous access devices.
    Timoney JP; Malkin MG; Leone DM; Groeger JS; Heaney ML; Keefe DL; Klang M; Lucarelli CD; Muller RJ; Eng SL; Connor M; Small TN; Brown AE; Saltz LB
    J Clin Oncol; 2002 Apr; 20(7):1918-22. PubMed ID: 11919252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urokinase in the treatment of occluded central venous catheters in children.
    Winthrop AL; Wesson DE
    J Pediatr Surg; 1984 Oct; 19(5):536-8. PubMed ID: 6502422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interventions for restoring patency of occluded central venous catheter lumens (Review).
    van Miert C; Hill R; Jones L
    Evid Based Child Health; 2013 Mar; 8(2):695–749. PubMed ID: 24482900
    [No Abstract]   [Full Text] [Related]  

  • 38. Regional thrombolysis with urokinase for central venous catheter-related thrombosis in patients undergoing high-dose chemotherapy with autologous blood stem cell rescue.
    Schindler J; Bona RD; Chen HH; Feingold JM; Edwards RL; Tutschka PJ; Bilgrami S
    Clin Appl Thromb Hemost; 1999 Jan; 5(1):25-9. PubMed ID: 10725979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [New thrombolytic agents in myocardial infarction].
    Charbonnier B; Lang M; Brochier M
    Arch Mal Coeur Vaiss; 1987 Nov; 80(12):1785-91. PubMed ID: 3128222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cerebral venous congestion as indication for thrombolytic treatment.
    Tsai FY; Kostanian V; Rivera M; Lee KW; Chen CC; Nguyen TH
    Cardiovasc Intervent Radiol; 2007; 30(4):675-87. PubMed ID: 17573553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.